PD-1 was negative in the L-HES and T-CUS patients mentioned above, which was useful to distinguish AITL from L-HES and T-CUS of sCD3-/CD4+ immunophenotyping. This evidence concerns the gene CD4 and angioimmunoblastic T-cell lymphoma.